Dr. Le Roux is Ireland-based University College Dublin’s head of pathology. Dr. Greve is the medical director of the Dutch Obesity Clinic in the Netherlands.
Here’s what you should know.
1. The advisory group is assisting GI Dynamics in its attempt to earn FDA approval for its EndoBarrier device.
2. The EndoBarrier is an endoscopically delivered device approved for type 2 diabetes and obesity treatment.
3. The EndoBarrier is currently only available for investigational use in the United States.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Mark Milone of Midwest Family Care
Colorectal cancer screening rates on the rise: 4 fast stats
Novel endoscopic device used for esophageal cancer diagnosis, staging: 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
